ARTICLE | Clinical News
STG320: Ph III data
February 3, 2017 8:35 PM UTC
Top-line data from a double-blind, Japanese Phase III trial in 438 patients ages 5-16 with perennial, house dust mite-induced allergic rhinitis showed that once-daily sublingual STG320 for 12 months m...